Pereira AC, Dias do Carmo
E, Dias da Silva MA, Blumer
Rosa LE. Matrix metalloproteinase gene polymorphisms and oral cancer. J Clin Exp Dent. 2012;4(5):e297-301.
doi:10.4317/jced.50859
References
1. Sorsa
T, Tjäderhane L, Salo T.
Matrix metalloproteinases (MMPs) in oral diseases.
Oral Dis. 2004;10:311-8.
http://dx.doi.org/10.1111/j.1601-0825.2004.01038.x
PMid:15533204
2. Slavkin
HC. The human genome, implications for oral health and diseases, and dental
education. J Dent Educ. 2001;65:463-79.
PMid:11425251
3. Ye S. Polymorphism in matrix
metalloproteinase gene promoters: implication in regulation of gene expression
and susceptibility of various diseases. Matrix Biol. 2000;19:623-9.
http://dx.doi.org/10.1016/S0945-053X(00)00102-5
PMid: 11102751
4. Kerkelä
E, Saarialho-Kere U. Matrix metalloproteinases
in tumor progression: focus on basal and squamous
cell skin cancer. Exp Dermatol. 2003;12:109-25.
http://dx.doi.org/10.1034/j.1600-0625.2003.120201.x
PMid:12702139
5. Li WP, Anderson CJ. Imaging
matrix metalloproteinase expression in tumors. Q J Nucl
Med. 2003;47:201-8.
PMid:12897711
6. Hidalgo M, Eckhardt
SG. Development of matrix metalloproteinase inhibitors in cancer therapy. J Natl Cancer Inst. 2001;93:178-93.
http://dx.doi.org/10.1093/jnci/93.3.178
PMid: 11158186
7. Chakraborti
S, Mandal M, Das S, Mandal
A, Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem. 2003;253:269-85.
http://dx.doi.org/10.1023/A:1026028303196
PMid:14619979
8. Nabeshima
K, Inoue T, Shimao Y, Sameshima
T. Matrix metalloproteinases in tumor invasion: role
for cell migration. Pathol Int. 2002;52:255-64.
http://dx.doi.org/10.1046/j.1440-1827.2002.01343.x
PMid:12031080
9. Cao ZG, Li CZ. A single
nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances
oral squamous cell carcinoma susceptibility in a
Chinese population. Oral Oncol. 2006;42:32-8.
http://dx.doi.org/10.1016/j.oraloncology.2004.08.015
PMid:16256416
10. Hong SD, Hong SP, Lee JI, Lim
CY. Expression of matrix metalloproteinase-2 and -9 in oral squamous
cell carcinomas with regard to the metastatic potential. Oral Oncol. 2000;36:207-13.
http://dx.doi.org/10.1016/S1368-8375(99)00088-3
PMid: 10745174
11. Katayama A, Bandoh N, Kishibe K, Takahara M, Ogino T, Nonaka S, et al. Expressions of matrix metalloproteinases
in early-stage oral squamous cell carcinoma as
predictive indicators for tumor metastases and prognosis. Clin
Cancer Res. 2004;10:634-40.
http://dx.doi.org/10.1158/1078-0432.CCR-0864-02
PMid:14760086
12. Ikebe
T, Shinohara M, Takeuchi H, Beppu M, Kurahara S, Nakamura S, et al. Gelatinolytic
activity of matrix metalloproteinase in tumor tissues correlates with the
invasiveness of oral cancer. Clin Exp Metastasis.
1999;17:315-23.
http://dx.doi.org/10.1023/A:1006642428826
PMid: 10545018
13. Jordan RC, Macabeo-Ong
M, Shiboski CH, Dekker N, Ginzinger
DG, Wong DT, et al. Overexpression of matrix
metalloproteinase-1 and -9 mRNA is associated with progression of oral
dysplasia to cancer. Clin Cancer Res. 2004;10:6460-5.
http://dx.doi.org/10.1158/1078-0432.CCR-04-0656
PMid:15475433
14. Lin SC, Chung MY, Huang JW, Shieh TM, Liu CJ, Chang KW. Correlation between functional
genotypes in the matrix metalloproteinases-1 promoter and risk of oral squamous cell carcinomas. J Oral Pathol
Med. 2004;33:323-6.
http://dx.doi.org/10.1111/j.1600-0714.2004.00214.x
PMid: 15200479
15. Ye S, Dhillon
S, Turner SJ, Bateman AC, Theaker JM, Pickering RM,
et al. Invasiveness of cutaneous malignant melanoma
is influenced by matrix metalloproteinase 1 gene polymorphism. Cancer Res. 2001;61:1296-8.
PMid:11245423
16. Hinoda Y, Okayama N, Takano N, Fujimura K, Suehiro Y, Hamanaka Y, et al. Association of functional polymorphisms
of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer. Int J Cancer. 2002;102:526-9.
http://dx.doi.org/10.1002/ijc.10750
PMid:12432557
17. Ghilardi
G, Biondi ML, Caputo M, Leviti
S, DeMonti M, Guagnellini
E, et al. A single nucleotide polymorphism in the matrix metalloproteinase-3
promoter enhances breast cancer susceptibility. Clin
Cancer Res. 2002;8:3820-3.
PMid:12473595
18. Grieu
F, Li WQ, Iacopetta B. Genetic polymorphisms in the
MMP-2 and MMP-9 genes and breast cancer phenotype. Breast Cancer Res Treat.
2004;88:197-204.
http://dx.doi.org/10.1007/s10549-004-0595-6
PMid:15609121
19. Hirata H, Okayama N, Naito K,
Inoue R, Yoshihiro S, Matsuyama H, et al. Association of a haplotype
of matrix metalloproteinase (MMP)-1 and MMP-3 polymorphisms with renal cell
carcinoma. Carcinogenesis. 2004;25:2379-84.
http://dx.doi.org/10.1093/carcin/bgh254
PMid:15319295
20. Zhou Y, Yu
C, Miao X, Tan W, Liang G, Xiong P, et al. Substantial reduction in risk of breast cancer
associated with genetic polymorphisms in the promoters of the matrix
metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes. Carcinogenesis. 2004;25:399-404.
http://dx.doi.org/10.1093/carcin/bgh020
PMid:14604886
21. Matsumura S, Oue N, Nakayama H, Kitadai Y, Yoshida K, Yamaguchi
Y, et al. A
single nucleotide polymorphism in the MMP-9 promoter affects tumor progression
and invasive phenotype of gastric cancer. J Cancer Res Clin
Oncol. 2005;131:19-25.
http://dx.doi.org/10.1007/s00432-004-0621-4
PMid:15565457
22. Lai HC, Chu CM, Lin YW, Chang
CC, Nieh S, Yu MH, et al. Matrix metalloproteinase 1
gene polymorphism as a prognostic predictor of invasive cervical cancer. Gynecol Oncol. 2005;96:314-9.
http://dx.doi.org/10.1016/j.ygyno.2004.09.065
PMid:15661214
23. Awakura Y, Ito N, Nakamura E, Takahashi T, Kotani H, Mikami Y, et al. Matrix metalloproteinase-9 polymorphisms and renal
cell carcinoma in a Japanese population. Cancer Lett.
2006;241:59-63.
http://dx.doi.org/10.1016/j.canlet.2005.10.005
PMid:16466849
24. Przybylowska
K, Kluczna A, Zadrozny M, Krawczyk T, Kulig A, Rykala J, et al. Polymorphisms of the promoter regions of
matrix metalloproteinases genes MMP-1 and MMP-9 in
breast cancer. Breast Cancer Res Treat. 2006;95:65-72.
http://dx.doi.org/10.1007/s10549-005-9042-6
PMid:16267613
25. Tu
HF, Liu CJ, Chang CS, Lui MT, Kao SY, Chang CP, et
al. The functional (-1171 5A-->6A) polymorphisms of matrix metalloproteinase
3 gene as a risk factor for oral submucous fibrosis
among male areca users. J Oral Pathol Med.
2006;35:99-103.
http://dx.doi.org/10.1111/j.1600-0714.2006.00370.x
PMid:16430740
26. Dunleavey
L, Beyzade S, Ye S. Rapid genotype analysis of the
matrix metalloproteinase-1 gene 1G/2G polymorphism that is associated with risk
of cancer. Matrix Biol. 2000;19:175-7.
http://dx.doi.org/10.1016/S0945-053X(00)00059-7
PMid: 10842101
27. Rutter
JL, Mitchell TI, Butticè G, Meyers J, Gusella JF, Ozelius LJ, et al. A
single nucleotide polymorphism in the matrix metalloproteinase-1 promoter
creates an Ets binding site and augments
transcription. Cancer Res. 1998;58:5321-5.
PMid:9850057
28. Hashimoto T, Uchida K,
Okayama N, Imate Y, Suehiro
Y, Hamanaka Y, et al. Association of matrix
metalloproteinase (MMP)-1 promoter polymorphism with head and neck squamous cell carcinoma. Cancer Lett.
2004;211:19-24.
http://dx.doi.org/10.1016/j.canlet.2004.01.032
PMid:15194213
29. Zinzindohoué
F, Lecomte T, Ferraz JM, Houllier AM, Cugnenc PH, Berger
A, et al. Prognostic significance of MMP-1 and MMP-3 functional promoter
polymorphisms in colorectal cancer. Clin Cancer Res.
2005;11:594-9.
PMid:15701845
30. Price SJ, Greaves DR, Watkins
H. Identification of novel, functional genetic variants in the human matrix
metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional
regulation. J Biol Chem. 2001;276:7549-58.
http://dx.doi.org/10.1074/jbc.M010242200
PMid:11114309
31. Lin SC, Lo SS, Liu CJ, Chung
MY, Huang JW, Chang KW. Functional genotype in matrix metalloproteinases-2
promoter is a risk factor for oral carcinogenesis. J Oral Pathol
Med. 2004;33:405-9.
http://dx.doi.org/10.1111/j.1600-0714.2004.00231.x
PMid:15250832
32. Yu C, Pan K, Xing D, Liang G,
Tan W, Zhang L, et al. Correlation between a single nucleotide polymorphism in
the matrix metalloproteinase-2 promoter and risk of lung cancer. Cancer Res.
2002;62:6430-3.
PMid:12438229
33. Miao X, Yu C, Tan W, Xiong P, Liang G, Lu W, et al. A functional polymorphism in
the matrix metalloproteinase-2 gene promoter (-1306C/T) is associated with risk
of development but not metastasis of gastric cardia adenocarcinoma. Cancer Res. 2003;63:3987-90.
PMid:12873995
34. Ye S, Watts GF, Mandalia S, Humphries SE, Henney
AM. Preliminary report: Genetic variation in the human stromelysin
promoter is associated with progression of coronary atherosclerosis. Br Heart
J. 1995;73:209-15.
http://dx.doi.org/10.1136/hrt.73.3.209
PMid: 7727178
35. Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries
SE, Henney AM. Progression of coronary
atherosclerosis is associated with a common genetic variant of the human
stromelysin-1 promoter which results in reduced gene expression. J Biol Chem. 1996;271:13055-60.
http://dx.doi.org/10.1074/jbc.271.22.13055
PMid:8662692
36. Krippl
P, Langsenlehner U, Renner W, Yazdani-Biuki
B, Köppel H, Leithner A, et
al. The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and
breast cancer. Clin Cancer Res. 2004;10:3518-20.
http://dx.doi.org/10.1158/1078-0432.CCR-04-0010
PMid:15161710
37. Zhang J, Jin X, Fang S, Li Y,
Wang R, Guo W, et al. The functional SNP in the
matrix metalloproteinase-3 promoter modifies susceptibility and lymphatic
metastasis in esophageal squamous cell carcinoma but
not in gastric cardiac adenocarcinoma.
Carcinogenesis. 2004;25:2519-24.
http://dx.doi.org/10.1093/carcin/bgh269
PMid:15319302
38. Zhang B, Ye S, Herrmann SM,
Eriksson P, de Maat M, Evans A, et al. Functional
polymorphism in the regulatory region of gelatinase B
gene in relation to severity of coronary atherosclerosis.Circulation.
1999;99:1788-94.
http://dx.doi.org/10.1161/01.CIR.99.14.1788
PMid:10199873
39. Vairaktaris
E, Vassiliou S, Nkenke E, Serefoglou Z, Derka S, Tsigris C, et al. A metalloproteinase-9 polymorphism which
affects its expression is associated with increased risk for oral squamous cell carcinoma. Eur J Surg Oncol. 2008;34:450-5.
http://dx.doi.org/10.1016/j.ejso.2007.03.024
PMid:17498910
40. Tu
HF, Wu CH, Kao SY, Liu CJ, Liu TY, Lui MT. Functional
-1562 C-to-T polymorphism in matrix metalloproteinase-9 (MMP-9) promoter is
associated with the risk for oral squamous cell
carcinoma in younger male areca users. J Oral Pathol
Med. 2007;36:409-14.
http://dx.doi.org/10.1111/j.1600-0714.2007.00552.x
PMid: 17617834